A new anti-inflammatory drug moving into phase two clinical trials to treat two serious diseases was built on a scientific collaboration with UO chemist, Bruce Branchaud.
Read more in AroundtheO and the Daily Emerald:
Drug entering clinical trials has fingerprint of UO chemist
New drug developed by UO chemist could help kidney disease sufferers